Ingelvac CircoFLEX-MycoFLEX Processed under FDA Memorandum Circular 2021-001. Formulation: Each 2 mL (dose) contains: Porcine Circovirus Type 2, ORF 2........................>1 RP Mesomycoplasma hyopneumoniae (B-3745 Isolate, J Strain) .........> 1RP RP - Relative Potency Suspension for Injection (IM)

Valsts: Filipīnas

Valoda: angļu

Klimata pārmaiņas: FDA (Food And Drug Administration)

Aktīvā sastāvdaļa:

Inactivated Porcine Circovirus Type 2 (PCV2) Mesomycoplasma hyopneumoniae Vaccine (Vet.)

Pieejams no:

Boehringer Ingelheim Animal Health Philippines, Inc.; Distributor: Boehringer Ingelheim Animal Health Philippines, Inc.

SNN (starptautisko nepatentēto nosaukumu):

Inactivated Porcine Circovirus Type 2 (PCV2) Mesomycoplasma hyopneumoniae Vaccine (Vet.)

Deva:

Processed under FDA Memorandum Circular 2021-001. Formulation: Each 2 mL (dose) contains: Porcine Circovirus Type 2, ORF 2........................>1 RP Mesomycoplasma hyopneumoniae (B-3745 Isolate, J Strain) .........> 1RP RP - Relative Potency

Zāļu forma:

Suspension for Injection (IM)

Vienības iepakojumā:

HDPE Bottles (2) with Rubber Stopper and Aluminum Seal x 50 mL (Box of 1’s)

Ražojis:

Boehringer Ingelheim Animal Health USA Inc., U.S.A

Autorizācija datums:

2022-06-17